Santen Pharmaceutical (SNPHY.US) Latest Stock News - Major News Analysis

Event Tracking

Nov7

Santen Pharmaceutical released FY2026 Q2 earnings on November 6 After-Market EST, actual revenue USD 465.19 M (forecast USD 470.41 M), actual EPS USD 0.1651

00:00

Santen Pharmaceutical released FY2026 Semi-Annual Earnings on November 6 After-Market EST, actual revenue USD 940.07 M (forecast USD 925.11 M), actual EPS USD 0.2843

00:00

Oct30

Santen Pharmaceutical to Release FY2026 Q2 Earnings on November 6 After-Market EST, Forecast Revenue USD 457.85 M

00:10

Aug7

Santen Pharmaceutical released FY2026 Q1 earnings on August 7 After-Market (EST), actual revenue USD 474.84 M (forecast USD 499.7 M), actual EPS USD 0.1193

23:00

Santen Pharmaceutical (ADR) Q2 2025 Revenue Down 8.1%, Net Profit Down 44.7%

06:38

Jul31

Santen Pharmaceutical to Release FY2026 Q1 Earnings on August 7, 2025, After-Market EST; Forecast Revenue USD 503.95 M

00:08